Eng

Borsch Med Partners with Unity Pharmacies to Help Elderly Access Zeria Chondroitin-based Joint Health Supplements in Support of Healthy Ageing in Singapore

PR Newswire (美通社)
更新於 2天前 • 發布於 2天前 • PR Newswire

SINGAPORE, Nov. 29, 2024 /PRNewswire/ -- Leading health and nutrition company, Borsch Med Pte Ltd (Borch Med) has announced that Zeria chrondroitin-based joint health supplements are now available at selected Unity pharmacies in Singapore. The enhanced distribution network of the Japanese-made supplements underscores Borsch Med's commitment to support Singapore's population as they embrace healthy and active ageing.

Chondroitin is a key component of cartilage that decreases with age and plays an essential role in maintaining cartilage volume and joint lubrication [1]. Regular chondroitin supplementation can help to relieve discomfort, support cartilage regeneration, and allow individuals to stay active [2].

廣告(請繼續閱讀本文)

Said Mr Goh Kai Kui, CEO of Borsch Med, "We are not only proud to join ongoing public health efforts by making Zeria chrondrotin-based joint health supplements more accessible to the elderly, but also support the needs of middle-aged and younger active individuals seeking preventive joint care, so they too can enjoy a better quality of life as they enter their golden years."

Singapore is one of the fastest aging populations in Asia [3], with an estimated one-third of all Singaporeans reaching the age of 65 and over by 2035 [4]. About 37% of respondents of a nationwide study to gauge the impact of policies aimed at supporting older people and their caregivers and families reported three or more chronic health conditions in 2017, up from 19.8% in a 2009 study [5]. Chronic health conditions such as diabetes [6] have been known to contribute to a lack of joint mobility, especially in the elderly.

The Joint Health Supplements Now Available at Unity:

廣告(請繼續閱讀本文)

Borsch Med's Chondroitin-based product line by Zeria caters to a range of joint health needs:

  • Chondro Max: Formulated for individuals experiencing persistent joint pain, this high chondroitin complex content supplement is designed for those who wish to maintain a vibrant, active lifestyle. It supports cartilage health, helping relieve daily joint discomfort.
  • Chondro Support: Targeted for active individuals who occasionally experience joint pain from overuse or injury, Chondro Support offers a balanced formulation to enhance joint health, relieve mild discomfort, and aid in cartilage regeneration.
  • Lively & Healthy Glucosamine & Chondroitin: Ideal for those leading active lifestyles, this blend is a preventive measure against joint health issues. It combines glucosamine and chondroitin to promote cartilage maintenance and joint health as a precaution against musculoskeletal discomforts in later years.

About Borsch Med Pte Ltd.

Established in 2004, Borsch Med Pte Ltd (Borch Med) is a leading distributor and manufacturer of healthcare and nutrition products in Singapore. Borsch Med is operated and managed by professionals in Goh Joo Hin Pte Ltd (Goh Joo Hin), which was established in 1940. For more information, please visit:

廣告(請繼續閱讀本文)

About Zeria Pharmaceutical Co. Ltd.

Founded in 1955 and headquartered in Tokyo, Zeria Pharmaceutical Co. Ltd. (Zeria) is a leader in chondroitin-based joint health products. Zeria operates in more than 10 countries globally. Under its ethical pharmaceuticals business it manufactures, sells, imports and exports pharmaceutical and non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals and reagents.

Under its consumer healthcare business, it manufactures, sells, imports and exports cosmetics, health foods, hygienic goods, alcohol beverages and soft drinks among others. For more information on Zeria visit:

References:

[1]. Watanabe, H., Chondroitin Sulfate in Cartilage. In: Endo, T., Seeberger, P., Hart, G., Wong, CH., Taniguchi, N. (eds) Glycoscience: Biology and Medicine. Springer, Tokyo.
[2]. Rabade, A., Viswanatha, G.L., Nandakumar, K. et al. Evaluation of efficacy and safety of glucosamine sulfate, chondroitin sulfate, and their combination regimen in the management of knee osteoarthritis: a systematic review and meta-analysis. Inflammopharmacol 32, 1759–1775 (2024).
[3].
[4].
[5].
[6].

查看原始文章

更多 Eng 相關文章

World Insights: Ukraine marks significant shift of stance on potential ceasefire with Russia
XINHUA
ROLLER Recognized on the AFR Fast 100 List for Exceptional International Growth
PR Newswire (美通社)
Shanghai welcomes first batch of visa-free passengers from Japan
XINHUA
Blooming business of Yunnan's Chinese New Year flowers
XINHUA
Returning home remains dream out of reach for many displaced Lebanese
XINHUA
UN urges immediate ceasefire, dialogue amid latest conflict in Syria
XINHUA
Annual family commemoration for Nanjing Massacre victims launched in east China
XINHUA
Chinese FM meets counterparts of Kazakhstan, Tajikistan, Uzbekistan
XINHUA
Winter brings surge in "silver hair" travelers on China-Laos Railway
XINHUA
New direct air route links SW China's Sichuan with Vienna
XINHUA
Foreign diplomats applaud China's green growth
XINHUA
Kenya issues floods alert amid heavy rains
XINHUA
Xinhua Commentary: China's visa-free policy demonstrates greater openness
XINHUA
PFAS chemicals detected in 20 pct of Japanese tap water in gov't survey
XINHUA
10-man Botafogo clinches first Copa Libertadores crown
XINHUA
Xinhua News | New direct air route links SW China's Sichuan with Vienna
XINHUA
China boosts AIDS prevention with timely post-exposure care
XINHUA
Life guardians illuminate HIV/AIDS ward in south China
XINHUA
American donor of Japanese war crime photo album visits China's Tianjin
XINHUA
China-Pakistan border port in Xinjiang to operate year-round
XINHUA
GLOBALink | Faces of China: A train driver's dedication to 9,000 safe trips
XINHUA
InPics: Doctor in Nanning hospital treats HIV/AIDS patients with love, responsibility
XINHUA
Vietnam's top legislature approves investment of north-south high-speed railway
XINHUA
Defying Convention to Deepen Connections: Booking.com's Nine Predictions for Travel in 2025
PR Newswire (美通社)